Similar Articles
Peripheral and Cortical Silent Period in Parkinson's Disease and Effects of L-DOPA
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
Issue: 1998, Volume 4 - Issue 3-4
0
306
Movement Related Cortical Potentials and L-DOPA in Parkinson 's Disease
Sibel ÖZKAYNAK, Berrin AKTEKİN, Korkut YALTKAYA
Issue: 1998, Volume 4 - Issue 3-4
0
302
H-Reflex Recovery Ratios for Alfa Motor Neuron Excitability in Parkinson's Disease
Ayhan ÖZTÜRK, Hilmi UYSAL
Issue: 1998, Volume 4 - Issue 3-4
0
328
New Developments in Parkinson's Disease Management
M. Cenk AKBOSTANCI
Issue: 1998, Volume 4 - Issue 1-2
0
285
P300 and P300 Topographic Mapping in Parkinson's Disease
Raif ÇAKMUR, Fethi İDİMAN, Barış BAKLAN, Birsen KESKİN, Görsev YENER, Şakir FADILOĞLU
Issue: 1995, Volume 1 - Issue 4
0
308
THE THERAPY OF PARKINSON'S DISEASE: UNDERSTANDING AND MANAGING THE PROBLEMS
Bülent ELİBOL
Issue: 1995, Volume 1 - Issue 1
0
308
Neurophysiology and Neurology of the Face and Mimicry.
Cumhur ERTEKİN
Issue: 2005, Volume 11 - Issue 1 - Supplement 1
0
522
Association of anticholinergic burden with Parkinson's disease severity and stage
Ümmü Serpil Sari, Süleyman Emre Koçyiğit
DOI: 10.55697/tnd.2024.167
Issue: 2024, Volume 30 - Issue 4
533
495